Share on: logo linkedin

Evonik in brief

Develop ideas to market readiness as quick as possible

Evonik Industries (Evonik) was established under this brand in 2007 in Essen, Germany, after the consolidation of multiple companies having their respective chemical specialties under the lead of RAG-Beteiligungs-AG.

Evonik is owned by the German RAG-Stiftung  for 74.99%percent and the funds company CVC Capital Partners for 25.01.%.

With 150 years history in the chemical industry through the famous brands Degussa, Goldschmidt, HÜls, Röhm, Stockhausen or SKW Trostberg, Evonik sees itself as a juvenated company focusing on chemical specialties supported by high-growth mega-trends such as health, nutrition and resource efficiency.

Based in Germany, Evonik employs 33,000 personnel globally with commercial activities in more than 100 countries and productions units in 26 countries.

Evonik owns 24,000 patents and 7,500 trade marks.

With its niches strategy and selective acquisitions, Evonik is growing fast to become world leader in number of its chemical specialties.

From the success recorded since established as Evonik, the company intends to continue its ambitious growth strategy in the coming years and to further strengthen profitability.

Vertically Evonik continues to focus on chemicals specialties carrying potential high-growth.

Horizontally Evonik is looking for expansion in most attractive regions for its specialties.

Then Evonik support this development with integrated technology platforms in order to balance business activities, end-markets and regions.

Evonik Key Figures

 – 2011 Revenues: $18,9 billion

 – 2010 Revenues: $17,2 billion

 – 2009 Revenues: $13,6 billion

 – 2011 Earnings: $1,3 billion

 – 2010 Earnings: $0,9 billion

 – 2009 Earnings: $0,3 billion

 – 2011 Capital Expenditure: $1 billion

 – 2010 Capital Expenditure :$0,8 billion

 – 2009 Capital Expenditure: $0,7 billion

Evonik Projects and Business Highlights

In 2011, more than 70% of the revenues were generated outside Germany.

Among the key regions offering significant growth, Evonik put a special attention on Asia in targeting $5 billion revenues from this region in 2015.

To support it, Evonik will invest $2.5 billion in Asia on the same period through projects and R&D in order to increase the local production capabilities to 60%.

Anyway Germany remains the centric point of capital expenditure in concentrating 50% of the R&D efforts including the construction of a new Hydroxy-Terminated PolyButadiene (HTPB) production facility in Marl.

HTPB is used for the production of high performances structural adhesives.

Overseas, Evonik is working on several projects:

 –  Isophorone and isophorone diamine plant in China

 – H2O2 plant for HPPO technology plant in China

 – Greenfield polyamide 12 plant in Asia

 –  Integrated DL-methionine plant in Singapore

  – Superabsorbents facility in Saudi-Arabia

 – Superabsorbents facility in Saudi-Arabia

 Continuous improvement through operational excellence, is also a key driver of Evonik’s Market Leadership in the global chemical industry.

For more information and data about oil and gas and petrochemical projects go to Project Smart Explorer

Scroll to Top